Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jul 9;460(7252):231-6.
doi: 10.1038/nature08159.

Mechanisms promoting translocations in editing and switching peripheral B cells

Jing H Wang  1 , Monica Gostissa, Catherine T Yan, Peter Goff, Thomas Hickernell, Erica Hansen, Simone Difilippantonio, Duane R Wesemann, Ali A Zarrin, Klaus Rajewsky, Andre Nussenzweig, Frederick W Alt
Affiliations

Mechanisms promoting translocations in editing and switching peripheral B cells

Jing H Wang et al. Nature. .

Abstract

Variable, diversity and joining gene segment (V(D)J) recombination assembles immunoglobulin heavy or light chain (IgH or IgL) variable region exons in developing bone marrow B cells, whereas class switch recombination (CSR) exchanges IgH constant region exons in peripheral B cells. Both processes use directed DNA double-strand breaks (DSBs) repaired by non-homologous end-joining (NHEJ). Errors in either V(D)J recombination or CSR can initiate chromosomal translocations, including oncogenic IgH locus (Igh) to c-myc (also known as Myc) translocations of peripheral B cell lymphomas. Collaboration between these processes has also been proposed to initiate translocations. However, the occurrence of V(D)J recombination in peripheral B cells is controversial. Here we show that activated NHEJ-deficient splenic B cells accumulate V(D)J-recombination-associated breaks at the lambda IgL locus (Igl), as well as CSR-associated Igh breaks, often in the same cell. Moreover, Igl and Igh breaks are frequently joined to form translocations, a phenomenon associated with specific Igh-Igl co-localization. Igh and c-myc also co-localize in these cells; correspondingly, the introduction of frequent c-myc DSBs robustly promotes Igh-c-myc translocations. Our studies show peripheral B cells that attempt secondary V(D)J recombination, and determine a role for mechanistic factors in promoting recurrent translocations in tumours.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Role of AID and RAG in Generating IgH, Igκ, and Igλ breaks in CXc/- Splenic B cells
a, Upper: Diagram of IgH FISH probes. An intact IgH shows co-localized red and green signals while a broken locus appears as split red and green signals. Middle: Example of metaphase FISH showing IgH breaks. Lower: Quantification of IgH abnormalities in day4 αCD40/IL4-activated control (n=6), CXc/− (n=9), CXc/−A−/− (n=5) and CXc/−RAGc (n=8) splenic B cells (details in Suppl. Table 1). b, Upper: Diagram of Igλ FISH probes. Intact Igλ shows co-localized green and red signals, Igλ breaks appear as split green and red signals, either free or in translocations. Middle: Examples of metaphase FISH showing Igλ breaks (left) and an Igλ break and dicentric translocation (right). Lower: Quantification of Igλ abnormalities in day4 αCD40/IL4-activated control (n=11), CXc/− (n=11), CXc/−A−/− (n=3), CXc/−RAG2c (n=8) splenic B cells (details in Suppl. Table 3). c, Upper: Diagram of Igκ FISH probes. Igκ breaks are scored similarly as Igλ breaks. Middle: Examples of metaphase FISH showing an Igκ break (left) and Igκ break and translocations (right), involving both centromeric and telomeric portions of chromosome 6. Lower: Quantification of Igκ abnormalities in day4 αCD40/IL4-activated control (n=10), CXc/− (n=11), CXc/−A−/− (n=3), CXc/−RAGc (n=7) splenic B cells (details in Suppl. Table 4). d, Upper: Diagram of Igλ 3D interphase FISH Probes. Middle: Representative 3D interphase FISH showing intact Igλ (co-localization of green and red signals) and Igλ breaks (split green and red signals) (details in Suppl. Fig. 4). Lower: Quantification of Igλ abnormalities by 3D interphase FISH on day 0 (n=3) or day 4 (n=3) αCD40/IL4-activated splenic B cells. We could not do similar assays for Igκ due to the large size of this locus (greater than 3Mb). In all panels, data are presented as mean ± s.e.m. Statistical analyses were calculated by a Student's t-Test with two-tailed distribution.
Figure 2
Figure 2. Frequent IgH/Igλ translocations in activated Xrcc4-deficient splenic B cells
a, Top left: Diagram showing 3′Igλ probe (green) on chromosome 16 and 3′IgH probe (red) on chromosome 12. Bottom left: Representative Igλ/IgH translocation showing green and red signals juxtaposed on a dicentric chromosome (yellow arrow). Right: Quantification of IgH/Igλ translocations in day4 αCD40/IL4-activated control (n=2) or CXc/− (n=4) B cells analyzed by metaphase FISH (details in Suppl. Table 8). Data are presented as mean ± std. b, PCR-isolated Igh/Igλ translocation junctions from day4 activated CXc/− B cells (n=3) (primers indicated by horizontal black arrows). Junctional sequences are shown in Suppl. Fig. 11. A vertical green arrow indicates breakpoints. For a given translocation, the same number is used to indicate the corresponding IgH and Igλ breakpoints, with the IgH breakpoint denoted by a (') symbol.
Figure 3
Figure 3. Frequent cell-type and Igλ locus-specific IgH/Igλ co-localization
a, Top: Diagram showing 3′IgH (green) and 3′Igλ (red) probes used for 3D interphase FISH. Bottom: Representative co-localization of IgH/Igλ in day 0 control and CXc/− B cell interphase nuclei. b, Schematic map of Igλ, C2 and K10 BAC probes on chromosome 16. c, Quantification of co-localization of IgH-Igλ, IgH-C2, or IgH-K10 loci in nuclei of day 0 control and CXc/− splenic B cells and in nuclei of thymocytes (details in Suppl. Tables 9 and 11). d, Quantification of co-localization of IgH-Igλ, IgH-C2, or IgH-K10 loci in day3.5-activated control or CXc/− peripheral B cells (details in Suppl. Table 10). At least three mice were analyzed per data set; data are presented as mean ± s.e.m.
Figure 4
Figure 4. DSBs in c-myc are rate-limiting for IgH/c-myc translocations in activated splenic B cells
a, Frequency of IgH/c-myc translocations from day4 αCD40/IL4-activated wt (n=4) and CXc/− (n=4) splenic B cells, or B cells harboring c-myc25ISceI/wt (n=3) or c-mycwt/wt (n=1) infected with either control or ISceI-expressing retrovirus (details in Suppl. Fig. 13 and 15). b, Top: Schematic showing c-myc (red) probe on chromosome 15 and 3′IgH (green) probe on chromosome 12. Bottom: Representative images of IgH/c-myc co-localization in day 0 control and CXc/− B cell interphase nuclei. c, Quantification of IgH/c-myc association by 3D interphase FISH in control and CXc/− splenic B cells (n=3), and ES cells (n=3). Cells were analyzed at the indicated time points before or after stimulation. d, Schematic showing the wt c-myc allele (c-mycwt) and the modified c-myc allele containing 25 ISceI sites (c-myc25ISceI). e, Top left: Diagram of c-myc FISH probes. Bottom left: Representative c-myc abnormalities in αCD40/IL-4-activated c-myc25ISceI/wt B cells infected with IsceI-expressing retrovirus, appearing as green and red signals on separate chromosome fragments (white arrows). Bottom right: Quantification of c-myc breaks by metaphase FISH on day4 αCD40/IL4-activated B cells harboring either c-myc25ISceI/wt (n=4) or c-mycwt/wt (n=1) alleles after infection with control or ISceI-expressing retrovirus. Data are presented as mean ± std (details in Suppl. Table 16). High titer retrovirus infection appears to inhibit end joining allowing break visualization (see online methods).
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Jung D, Alt FW. Unraveling V(D)J recombination; insights into gene regulation. Cell. 2004;116:299–311. - PubMed
    1. Rooney S, Chaudhuri J, Alt FW. The role of the non-homologous end-joining pathway in lymphocyte development. Immunol Rev. 2004;200:115–31. - PubMed
    1. Bassing CH, Swat W, Alt FW. The mechanism and regulation of chromosomal V(D)J recombination. Cell. 2002;109(Suppl):S45–55. - PubMed
    1. Gorman JR, Alt FW. Regulation of immunoglobulin light chain isotype expression. Adv Immunol. 1998;69:113–81. - PubMed
    1. Gay D, Saunders T, Camper S, Weigert M. Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med. 1993;177:999–1008. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources